Labour aims to capitalise on the growth potential of the cluster of businesses and academic institutes around Oxford, ...

The Cambridge, England-based and Tokyo-based pharmaceutical companies said the US Food & Drug Administration approved Enhertu for the treatment of adult patients with unresectable or metastatic ...

British finance minister Rachel Reeves spelled out her plans to revive the country's slow-moving economy on Wednesday, adding ...

Secretary of State for Science, Innovation and Technology Rt Hon Peter Kyle and Minister of State for Science, Research and ...

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...

British finance minister Rachel Reeves spelled out her plans to revive the country's slow-moving economy on Wednesday, adding ...

After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in Cambridge ... today is to not only unveil a building, but to also drive the next wave ...

But it only became a part of AstraZeneca last year, in a $39 billion deal. The building of a new rare disease hub in Barcelona demonstrates the Cambridge-based pharma giant’s dedication to its ...

AstraZeneca announced a USD570 million investment in Canada, creating more than 700 jobs, across all areas of the business. The Cambridge-based pharmaceuticals company said the investment will ...

The government keeps saying its main mission is to grow the economy. Now the chancellor has made it very clear that she wants ...